bazedoxifene has been researched along with Menopause in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (7.14) | 29.6817 |
2010's | 38 (90.48) | 24.3611 |
2020's | 1 (2.38) | 2.80 |
Authors | Studies |
---|---|
Chalise, P; Fabian, CJ; Gajewski, BJ; Goodman, ML; Hagan, CR; Kimler, BF; Koestler, DC; Kreutzjans, AL; Metheny, T; Nydegger, JL; Nye, L; Phillips, TA; Powers, KR; Winblad, O; Zalles, CM | 1 |
Choi, D; Kim, BM; Kim, SE; Lee, DY | 1 |
Abraham, L; Bobula, J; Bushmakin, AG; Komm, BS; Lavenberg, J; Pinkerton, JV | 1 |
Boucher, M; Morgenstern, D; Pickar, JH | 1 |
Pinkerton, JV | 1 |
Liu, J; VAN Heertum, K | 1 |
Gatti, D; Lello, S; Rossini, M; Sblendorio, I | 1 |
Appt, SE; Clarkson, TB; Ethun, KF; Floyd, E; Golden, D; Pajewski, NM | 1 |
Komm, BS; Mirkin, S | 1 |
Gallagher, JC; Tella, SH | 1 |
Moore, A | 1 |
Chandran, AB; Komm, BS; Mirkin, S; Ryan, KA | 1 |
Abraham, L; Bushmakin, AG; Cappelleri, JC; Mirkin, S; Pinkerton, JV | 1 |
Lewiecki, EM; Sharifi, M | 1 |
Abraham, L; Komm, BS; Messig, M; Mirkin, S; Pinkerton, JV; Ryan, KA | 1 |
Carris, N; Kutner, S; Reilly-Rogers, S | 1 |
Komm, BS; Mirkin, S; Pan, K; Skouby, SO; Thompson, JR | 1 |
Currie, H; Dragon, E; Mikkola, TS; Palacios, S | 1 |
Chines, A; Mirkin, S; Pan, K; Ryan, KA; Stevenson, JC | 1 |
Arnal, JF; Gourdy, P; Trémollières, F; Valera, MC | 1 |
Hauck, F; Johnson, K | 1 |
Karel, L; Santoro, N; Umland, EM | 1 |
Archer, DF; Kagan, R; Komm, BS; Mirkin, S; Pan, K; Pickar, JH; Pinkerton, JV; Thompson, JR | 1 |
Abraham, L; Bushmakin, AG; Cappelleri, JC; Komm, BS; Pinkerton, JV | 2 |
Hadji, P; Komm, BS; Mirkin, S; Ryan, KA; Yu, CR | 1 |
Abraham, L; Bushmakin, AG; Dragon, E; Komm, BS; Pinkerton, JV | 1 |
Crider, M; Hill, DA; Hill, SR | 1 |
Gillespie, JA; Parish, SJ | 1 |
Mitwally, MF | 1 |
Constantine, G; Dorin, MH; Gass, MLS; Lobo, RA; Pickar, JH; Pinkerton, JV; Ronkin, S | 1 |
Stovall, DW | 1 |
Archer, DF | 1 |
Mirkin, S; Pickar, JH | 1 |
Lindsay, R | 1 |
Levine, JP | 1 |
Palacios, S | 1 |
Pinkerton, JV; Stovall, DW; Tanner-Kurtz, K | 1 |
Mirkin, S; Pickar, JH; Pinkerton, JV; Racketa, J | 1 |
Calaf Alsina, J; Coronado Martín, PJ | 1 |
Archer, DF; Baracat, E; Constantine, G; Northington, R; Nunes, MG; Pickar, JH; Ronkin, S | 1 |
26 review(s) available for bazedoxifene and Menopause
Article | Year |
---|---|
Bazedoxifene for HRT?
Topics: Drug Combinations; Drug Costs; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause | 2017 |
Tissue selective estrogen complex (TSEC): a review.
Topics: Bone Density; Breast Neoplasms; Drug Synergism; Drug Therapy, Combination; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators | 2018 |
Tissue-selective Estrogen Complex for Menopausal Hormone Therapy.
Topics: Bone Density; Breast Density; Dyspareunia; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Selective Estrogen Receptor Modulators; Sleep Initiation and Maintenance Disorders; Thromboembolism | 2018 |
Differential Effects of Progestogens Used for Menopausal Hormone Therapy.
Topics: Breast Neoplasms; Carbohydrate Metabolism; Cardiovascular Diseases; Carotid Intima-Media Thickness; Female; Hormone Replacement Therapy; Humans; Indoles; Lipids; Menopause; Progestins; Selective Estrogen Receptor Modulators; Stroke; Thromboembolism | 2018 |
Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis.
Topics: Aged; Drug Evaluation; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Spinal Fractures; Treatment Outcome | 2013 |
Tissue-selective estrogen complexes for postmenopausal women.
Topics: Breast; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Sleep; Uterus; Vaginal Diseases | 2013 |
Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.
Topics: Animals; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis; Selective Estrogen Receptor Modulators | 2013 |
Advances in menopausal therapy: the tissue-selective estrogen complex.
Topics: Adult; Aged; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Middle Aged; Selective Estrogen Receptor Modulators | 2013 |
Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms.
Topics: Estrogens; Estrogens, Conjugated (USP); Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators | 2014 |
Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.
Topics: Bone Density; Cell Line, Tumor; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Treatment Outcome | 2014 |
New pharmacological therapies for vasomotor symptom management: focus on bazedoxifene/conjugated estrogens and paroxetine mesylate.
Topics: Clinical Trials as Topic; Drug Combinations; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Mesylates; Paroxetine; Vasomotor System | 2014 |
Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
Topics: Adult; Amenorrhea; Bone Density; Breast; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Progestins; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Uterine Hemorrhage; Venous Thromboembolism | 2015 |
A Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Lipid Parameters in Postmenopausal Women From the Selective Estrogens, Menopause, and Response to Therapy (SMART) Trials.
Topics: Adult; Aged; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Indoles; Lipid Metabolism; Lipids; Menopause; Middle Aged; Postmenopause; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Treatment Outcome | 2015 |
From the Women's Health Initiative to the combination of estrogen and selective estrogen receptor modulators to avoid progestin addition.
Topics: Breast Neoplasms; Coronary Disease; Estrogen Receptor alpha; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Progestins; Selective Estrogen Receptor Modulators; Venous Thromboembolism; Women's Health | 2015 |
Conjugated Estrogens/Bazedoxifene (Duavee) for Menopausal Symptoms.
Topics: Bone Density Conservation Agents; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal | 2016 |
Bazedoxifene and Conjugated Equine Estrogen: A Combination Product for the Management of Vasomotor Symptoms and Osteoporosis Prevention Associated with Menopause.
Topics: Drug Combinations; Estrogens, Conjugated (USP); Hot Flashes; Humans; Indoles; Menopause; Osteoporosis | 2016 |
Hormone Therapy and Other Treatments for Symptoms of Menopause.
Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexanecarboxylic Acids; Dietary Supplements; Drug Therapy, Combination; Dyspareunia; Estrogen Replacement Therapy; Estrogens; Exercise Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypnosis; Indoles; Menopause; Paroxetine; Progestins; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vaginal Diseases; Vasomotor System; Venlafaxine Hydrochloride | 2016 |
The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Topics: Age Factors; Bone Remodeling; Breast Neoplasms; Cardiovascular Diseases; Drug Administration Routes; Drug Combinations; Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Quality of Life; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Sleep Wake Disorders; Time Factors; Vagina | 2017 |
Bazedoxifene: a selective estrogen-receptor modulator.
Topics: Bone Density Conservation Agents; Clinical Trials, Phase III as Topic; Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Women's Health | 2008 |
Aprela, a single tablet formulation of bazedoxifene and conjugated equine estrogens (Premarin) for the potential treatment of menopausal symptoms.
Topics: Clinical Trials, Phase III as Topic; Estrogen Receptor alpha; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Risk; Selective Estrogen Receptor Modulators; Tablets | 2010 |
Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms.
Topics: Aged; Animals; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators | 2010 |
Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
Topics: Amenorrhea; Bone Density; Breast; Clinical Trials, Phase III as Topic; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Multicenter Studies as Topic; Pain; Postmenopause; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators | 2010 |
Preventing osteoporosis with a tissue selective estrogen complex (TSEC) containing bazedoxifene/conjugated estrogens (BZA/CE).
Topics: Bone Density; Bone Density Conservation Agents; Clinical Trials, Phase III as Topic; Collagen Type I; Endometrium; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Peptides; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Treatment Outcome; Vaginal Diseases | 2011 |
Treating menopausal symptoms with a tissue-selective estrogen complex.
Topics: Atrophy; Body Mass Index; Climacteric; Endometrial Hyperplasia; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Vagina; Vasomotor System; Vulva; Women's Health | 2011 |
Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
Topics: Adult; Aged; Atrophy; Clinical Trials, Phase III as Topic; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis; Quality of Life; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Treatment Outcome; Vagina; Vaginal Diseases; Vulva | 2012 |
[Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action].
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Multicenter Studies as Topic; Organ Specificity; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Thromboembolism | 2013 |
11 trial(s) available for bazedoxifene and Menopause
Article | Year |
---|---|
Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot Study.
Topics: Aged; Biomarkers, Tumor; Breast; Breast Density; Breast Neoplasms; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Feasibility Studies; Female; Humans; Indoles; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Ki-67 Antigen; Mammography; Menopause; Middle Aged; Pilot Projects; Postmenopause; Progesterone; Quality of Life; Risk Factors; Testosterone; Vasomotor System | 2019 |
Time to first occurrence of breast pain and vaginal bleeding in phase 3 trials of CE/BZA.
Topics: Adult; Aged; Double-Blind Method; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Mastodynia; Menopause; Middle Aged; Placebos; Selective Estrogen Receptor Modulators; Time Factors; Uterine Hemorrhage | 2017 |
Evaluation of the measurement model and clinically important differences for menopause-specific quality of life associated with bazedoxifene/conjugated estrogens.
Topics: Adult; Aged; Double-Blind Method; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Quality of Life; Selective Estrogen Receptor Modulators; Surveys and Questionnaires; Treatment Outcome | 2014 |
Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene.
Topics: Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Female; Genital Diseases, Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Quality of Life; Selective Estrogen Receptor Modulators; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Vagina; Vaginal Diseases; Vulva; Vulvar Diseases | 2014 |
Effects of conjugated estrogens/bazedoxifene on lipid and coagulation variables: a randomized placebo- and active-controlled trial.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Lipid Metabolism; Menopause; Middle Aged; Postmenopause; Quality of Life; Treatment Outcome | 2015 |
Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 Trials.
Topics: Bone Density; Bone Density Conservation Agents; Breast; Drug Therapy, Combination; Endometrial Hyperplasia; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Incidence; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Selective Estrogen Receptor Modulators; Uterine Hemorrhage | 2016 |
Most bothersome symptom in women with genitourinary syndrome of menopause as a moderator of treatment effects.
Topics: Double-Blind Method; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Middle Aged; Pain, Intractable; Surveys and Questionnaires; Treatment Outcome; Vaginal Diseases | 2016 |
Relationship between changes in vasomotor symptoms and changes in menopause-specific quality of life and sleep parameters.
Topics: Decision Support Techniques; Double-Blind Method; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Quality of Life; Sleep Wake Disorders; Treatment Outcome; United Kingdom; United States | 2016 |
CE/BZA effects on bone and quality of life in European postmenopausal women: a pooled analysis.
Topics: Aged; Bone Density; Bone Remodeling; Collagen Type I; Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Europe; Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Peptides; Quality of Life; Selective Estrogen Receptor Modulators; Treatment Outcome; United States; Vasomotor System | 2016 |
Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.
Topics: Adult; Aged; Atrophy; Carbohydrate Metabolism; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Homocysteine; Hot Flashes; Humans; Indoles; Lipid Metabolism; Menopause; Middle Aged; Outpatients; Selective Estrogen Receptor Modulators; Treatment Outcome; Vagina | 2009 |
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women.
Topics: Adult; Aged; Double-Blind Method; Endometrium; Female; Humans; Indoles; Menopause; Middle Aged; Osteoporosis; Postmenopause; Selective Estrogen Receptor Modulators; Ultrasonography | 2005 |
5 other study(ies) available for bazedoxifene and Menopause
Article | Year |
---|---|
Effect of Tissue-Selective Estrogen Complex on Hip Structural Geometry in Postmenopausal Women: A 12-Month Study.
Topics: Absorptiometry, Photon; Biomechanical Phenomena; Bone Density; Estrogens; Female; Femur; Femur Neck; Hip; Hip Fractures; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Republic of Korea; Retrospective Studies | 2021 |
Effects of bazedoxifene, conjugated equine estrogens, and a tissue-selective estrogen complex containing both bazedoxifene and conjugated equine estrogens on cerebral artery atherosclerosis in postmenopausal monkeys.
Topics: Animals; Basilar Artery; Carotid Artery Diseases; Carotid Artery, Internal; Diet, Atherogenic; Drug Combinations; Estrogens; Estrogens, Conjugated (USP); Female; Haplorhini; Indoles; Intracranial Arteriosclerosis; Menopause; Random Allocation; Selective Estrogen Receptor Modulators; Severity of Illness Index | 2014 |
Direct and indirect effects of conjugated estrogens/bazedoxifene treatment on quality of life in postmenopausal women.
Topics: Double-Blind Method; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Models, Psychological; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Sexual Behavior | 2016 |
Selective estrogen receptor modulators: the future in menopausal treatment.
Topics: Female; Forecasting; Humans; Indoles; Menopause; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes | 2011 |
Tissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms.
Topics: Adult; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Vasomotor System | 2011 |